Insider Selling: Phreesia, Inc. (NYSE:PHR) COO Sells 2,029 Shares of Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 2,029 shares of the company’s stock in a transaction that occurred on Monday, April 15th. The shares were sold at an average price of $22.86, for a total value of $46,382.94. Following the completion of the transaction, the chief operating officer now owns 754,903 shares in the company, valued at approximately $17,257,082.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Evan Roberts also recently made the following trade(s):

• On Monday, April 8th, Evan Roberts sold 7,178 shares of Phreesia stock. The shares were sold at an average price of $22.62, for a total value of $162,366.36.
• On Thursday, March 21st, Evan Roberts sold 25,962 shares of Phreesia stock. The shares were sold at an average price of $23.52, for a total value of $610,626.24.

Phreesia Trading Down 4.2 %

Phreesia stock opened at $21.67 on Friday. Phreesia, Inc. has a fifty-two week low of $12.05 and a fifty-two week high of $34.98. The firm’s fifty day moving average price is $24.28 and its 200-day moving average price is $21.28. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.02.

Phreesia (NYSE:PHR) last announced its earnings results on Thursday, March 14th. The company reported ($0.56) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.58) by $0.02. Phreesia had a negative net margin of 38.42% and a negative return on equity of 53.33%. The company had revenue of $95.00 million during the quarter, compared to analyst estimates of $93.52 million. During the same period in the previous year, the business earned ($0.72) earnings per share. The firm’s quarterly revenue was up 24.0% compared to the same quarter last year. As a group, analysts forecast that Phreesia, Inc. will post -1.48 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in PHR. International Assets Investment Management LLC grew its position in Phreesia by 1,987.3% in the fourth quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock worth $34,000 after acquiring an additional 1,411 shares in the last quarter. Captrust Financial Advisors grew its position in Phreesia by 154.6% in the second quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock worth $36,000 after acquiring an additional 866 shares in the last quarter. Acadian Asset Management LLC purchased a new position in Phreesia in the first quarter worth $43,000. State of Wyoming grew its position in Phreesia by 34.6% in the second quarter. State of Wyoming now owns 1,918 shares of the company’s stock worth $59,000 after acquiring an additional 493 shares in the last quarter. Finally, Tower Research Capital LLC TRC boosted its position in Phreesia by 85.4% during the third quarter. Tower Research Capital LLC TRC now owns 3,137 shares of the company’s stock valued at $80,000 after buying an additional 1,445 shares during the period. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the stock. Canaccord Genuity Group boosted their target price on shares of Phreesia from $36.00 to $37.00 and gave the company a “buy” rating in a report on Friday, March 15th. Needham & Company LLC reissued a “buy” rating and set a $29.00 target price on shares of Phreesia in a report on Friday, March 15th. Stephens reissued an “overweight” rating and set a $28.00 target price on shares of Phreesia in a report on Friday, March 22nd. JMP Securities boosted their target price on shares of Phreesia from $28.00 to $30.00 and gave the company a “market outperform” rating in a report on Thursday, March 21st. Finally, Barclays assumed coverage on shares of Phreesia in a report on Wednesday, January 3rd. They set an “overweight” rating and a $29.00 target price on the stock. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, Phreesia currently has a consensus rating of “Moderate Buy” and an average target price of $31.62.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.